DOT1L is an important player in the development and maintenance of MLL-rearranged AML, in which abnormal recruitment of DOT1L, particularly at MLL-fusion target genes, results in H3K79 hypermethylation and thus aberrant gene expression contributing to leukemic transformation [160,161,162]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.